Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Jones

Showing results (631-640 of 654) with videos related to

Pageof 66
Sort By:
Cell|March 9, 2019
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC MutagenesisMia Petljak, Ludmil B Alexandrov, Jonathan S Brammeld, et al.
Nature Genetics|January 14, 2014
RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemiaElli Papaemmanuil, Inmaculada Rapado, Yilong Li, et al.
Cell Reports|August 9, 2016
Direct Transcriptional Consequences of Somatic Mutation in Breast CancerAdam Shlien, Keiran Raine, Fabio Fuligni, et al.
Biomolecules|November 11, 2022
Replicative Instability Drives Cancer ProgressionBenjamin B Morris, Jason P Smith, Qi Zhang, et al.
Stem Cells Translational Medicine|February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesJames A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
NPJ Regenerative Medicine|January 6, 2018
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapiesLauren Scarfe, Nathalie Brillant, J Dinesh Kumar, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
Cancer Discovery|November 11, 2017
Genetic Predictors of Response to Systemic Therapy in Esophagogastric CancerYelena Y Janjigian, Francisco Sanchez-Vega, Philip Jonsson, et al.
Computational Toxicology (Amsterdam, Netherlands)|April 4, 2022
<i>In Silico</i> Approaches In Carcinogenicity Hazard Assessment: Current Status and Future NeedsRaymond R Tice, Arianna Bassan, Alexander Amberg, et al.
Cancer Cell|May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunityMengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Pageof 66

Showing results (631-640 of 654) with videos related to

Sort By:
Pageof 66
Cell|March 9, 2019
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC MutagenesisMia Petljak, Ludmil B Alexandrov, Jonathan S Brammeld, et al.
Nature Genetics|January 14, 2014
RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemiaElli Papaemmanuil, Inmaculada Rapado, Yilong Li, et al.
Cell Reports|August 9, 2016
Direct Transcriptional Consequences of Somatic Mutation in Breast CancerAdam Shlien, Keiran Raine, Fabio Fuligni, et al.
Biomolecules|November 11, 2022
Replicative Instability Drives Cancer ProgressionBenjamin B Morris, Jason P Smith, Qi Zhang, et al.
Stem Cells Translational Medicine|February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesJames A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
NPJ Regenerative Medicine|January 6, 2018
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapiesLauren Scarfe, Nathalie Brillant, J Dinesh Kumar, et al.
Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.
Cancer Discovery|November 11, 2017
Genetic Predictors of Response to Systemic Therapy in Esophagogastric CancerYelena Y Janjigian, Francisco Sanchez-Vega, Philip Jonsson, et al.
Computational Toxicology (Amsterdam, Netherlands)|April 4, 2022
<i>In Silico</i> Approaches In Carcinogenicity Hazard Assessment: Current Status and Future NeedsRaymond R Tice, Arianna Bassan, Alexander Amberg, et al.
Cancer Cell|May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunityMengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Pageof 66